Integral Derivatives’s Geron GERN Stock Holding History

Integral Derivatives’s Portfolio GERN Stock Details GERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-14,837	Closed	-$27K	–	796
2017 Q4	$27K	Buy	+14,837	New	+$30K	﹤0.01%	1085

Other funds holding GERN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return

Integral Derivatives's GERN Position: Q1 2018 in Review

Integral Derivatives sold out of Geron (GERN) in Q1 2018, closing a stake of 14,837 shares — an estimated $27K sold.

Integral Derivatives first reported a position in GERN in Q4 2017 and held it in 1 quarter. The position peaked at $27K in Q4 2017. 127 funds tracked by Wall St. Rank hold GERN as of Q1 2018.

Integral Derivatives reported no remaining Geron position as of Q1 2018 after selling out during the quarter.
Integral Derivatives sold 14,837 Geron shares in Q1 2018, an estimated $27K.
Integral Derivatives first reported a position in Geron in Q4 2017 and held it in 1 quarter.
Integral Derivatives's Geron position peaked at $27K in Q4 2017.
127 funds tracked by Wall St. Rank held Geron as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.